Quantcast

Goodwin Procter LLP News

Pharmaceutical company questions FDA's decision to delay approval of anti-opioid drug

By John Suayan | Apr 16, 2019

WASHINGTON (Legal Newsline) – A Pennsylvania-based pharmaceutical company is suing the Food and Drug Administration, acting FDA Commissioner Norman E. Sharpless, the Department of Health and Human Services and HHS Secretary Alex M. Azar II for allegedly delaying the approval of a drug product it claims would combat the opioid crisis.

The Record Network